SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-012312
Filing Date
2020-05-07
Accepted
2020-05-07 19:40:04
Documents
2
Period of Report
2020-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4542
2 EX-24 DOCUMENT attachment1.htm EX-24 4316
  Complete submission text file 0000899243-20-012312.txt   10443
Mailing Address HANNAH RUBINA 11 TEL AVIV L3 6937215
Business Address HANNAH RUBINA 11 TEL AVIV L3 6937215 972-52-873-9833
Israel Biotech Fund I, L.P. (Reporting) CIK: 0001652458 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39279 | Film No.: 20858252

Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)